Weiguo Shu
About Weiguo Shu
Weiguo Shu serves as the Lead Scientist Group Leader at ATCC, where he has worked since 2021. He has extensive experience in gene editing technologies and has held various scientific roles across multiple organizations.
Work at ATCC
Weiguo Shu has been serving as the Lead Scientist Group Leader at ATCC since 2021. In this role, he is responsible for overseeing research and development initiatives related to advanced gene editing technologies. Prior to his current position, he worked at ATCC as a Senior Scientist Group Leader from 2015 to 2021, contributing to various projects in cell line engineering. His extensive experience at ATCC highlights his commitment to advancing scientific research and product development within the organization.
Education and Expertise
Weiguo Shu has a strong educational background in molecular biology and genetics. He specializes in advanced gene editing technologies, including CRISPR/Cas9, ZFN, and TALEN. His expertise extends to induced pluripotent stem cell (iPSC) differentiation and developmental biology, which are critical areas in modern genetic research. This knowledge supports his work in product development and management in cell line engineering.
Background
Weiguo Shu began his research career as a Postdoctoral Researcher at the Molecular Cardiology Research Center at the University of Pennsylvania from 1999 to 2002. He then served as a Research Scientist at the same center until 2007. Following this, he held various positions in the biotechnology sector, including roles at Taconic (Xenogen Biosciences), SAGE Lab Sigma-Aldrich, and Genetic Engineering Technologies at Jackson Laboratory. His diverse background in research and management has equipped him with a comprehensive understanding of the biotechnology landscape.
Professional Experience
Weiguo Shu has accumulated significant professional experience in the field of biotechnology. He worked at Taconic (Xenogen Biosciences) as a Scientist from 2007 to 2010, and then at SAGE Lab Sigma-Aldrich as a Senior Scientist for one year. His role as Manager at Genetic Engineering Technologies at Jackson Laboratory from 2012 to 2014 further solidified his leadership skills. This trajectory demonstrates his ability to adapt and thrive in various research environments.
Achievements
Throughout his career, Weiguo Shu has been involved in product development and management within the field of cell line engineering. His contributions to advanced gene editing technologies have positioned him as a knowledgeable figure in the biotechnology sector. His work has implications for various applications in research and therapeutic development, reflecting his impact on the field.